AMY E. MCKEE, M.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

BIOCRYST PHARMACEUTICALS INC

Filing Date Source Excerpt
2023-04-27 Amy E. McKee, M.D. was initially appointed to the Board in September 2021... The Company’s Corporate Governance and Nominating Committee currently consists of Ms. Heggie, as its Chair (since February 2023), Mr. Abercrombie, Dr. Hutson, and Dr. McKee... 2022 Director Compensation: Amy E. McKee, M.D. total compensation $422,848.

Data sourced from SEC filings. Last updated: 2026-02-03